High-Grade Endometrial Carcinomas : Classification with Molecular Insights - 17/05/19
Doi : 10.1016/j.path.2019.02.003
Joseph W. Carlson, MD, PhD a, b, ⁎ 
, Denis Nastic, MD a, b
, Denis Nastic, MD a, b a Department of Oncology–Pathology, Karolinska Institutet, Stockholm SE-17176, Sweden
b Department of Clinical Pathology and Cytology, Karolinska University Hospital, Radiumhemmet P1:02, Stockholm SE-17176, Sweden
∗Corresponding author. Department of Clinical Pathology and Cytology, Karolinska University Hospital, Radiumhemmet P1:02, Stockholm SE-17176, Sweden.Department of Clinical Pathology and CytologyKarolinska University HospitalRadiumhemmet P1:02StockholmSE-17176Sweden
Abstract |
This article provides an overview of the current diagnosis of endometrial carcinoma subtypes and provides updates, including the most recent molecular findings from The Cancer Genome Atlas and others. Interpretation of relevant immunohistochemistry and critical diagnostic differential diagnosis with pitfalls are discussed.
El texto completo de este artículo está disponible en PDF.Keywords : Endometrial cancer, Molecular pathologic assessment, TCGA, POLE, MSI, p53, Prognosis
Esquema
| Disclosure Statement: This work was funded by grants from the Radiumhemmets forskningsfonder and Region Stockholm. |
© 2019
Elsevier Inc. Reservados todos los derechos.
Vol 12 - N° 2
P. 343-362 - juin 2019 Regresar al número
Artículo precedente
- Endometrial Carcinoma : Grossing, Frozen Section Evaluation, Staging, and Sentinel Lymph Node Evaluation
- Vinita Parkash, Oluwole Fadare
- Uterine Mesenchymal Tumors : Update on Classification, Staging, and Molecular Features
- Carlos Parra-Herran, Brooke E. Howitt
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?